Companies in #Influenza
Found 1 company operating in this sector.
Novavax is a vaccine company built on a recombinant protein-based nanoparticle platform and its saponin-based Matrix-M adjuvant, used in Nuvaxovid (NVX-CoV2373), its protein-based COVID-19 vaccine. The company develops adjuvanted vaccines for infectious diseases and partners with public-health bodies and manufacturers on supply and technology transfer.